AN EARLY PHASE-2 STUDY WITH XELODA(TM) (CAPECITABINE) IN PATIENTS WITH METASTATIC BREAST-CANCER
Citation
T. Saeki et al., AN EARLY PHASE-2 STUDY WITH XELODA(TM) (CAPECITABINE) IN PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 9, 1998, pp. 594-594
Categorie Soggetti
Oncology
SICI code
0923-7534(1998)9:<594:AEPSWX>2.0.ZU;2-E